# OnCo record seacraft-2 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/seacraft-2/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "seacraft-2", "NCT06346067" ;
  schema:name "A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)"@en ;
  schema:alternateName "SEACRAFT-2"@en ;
  schema:description "A phase 3 trial testing Naporafenib in melanoma, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/seacraft-2/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06346067> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2024-04-29" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/advanced-melanoma/> ;
  onco:drugs <https://onco.cc/drugs/naporafenib/> ;
  onco:companies <https://onco.cc/companies/erasca/> .